RecruitingNCT06340152
Multi-Omics for Maternal Health After Preeclampsia
Sponsor
University of California, San Diego
Enrollment
1,100 participants
Start Date
Dec 20, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years
Inclusion Criteria4
- Pregnant women 18 years of age to 50 years of age
- weeks gestation at time of enrollment
- Singleton pregnancy
- Planning to deliver at a study site (UCSD or VUMC)
Exclusion Criteria8
- Inability to give informed consent
- Intrauterine fetal demise
- Fetal genetic or structural anomaly
- Institutionalization for psychiatric disorder, mental deficiency or incarcerated
- Active or history of malignancy requiring major surgery or systemic chemotherapy
- Multi-fetal gestation or a twin demise at any gestational age
- Known maternal or fetal chromosomal anomalies
- Patients who plan to keep their placenta after delivery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06340152
Related Trials
Basic and Clinical Research of Pregnancy-Induced Hypertension
NCT074643791 location
Placental Biology in Health and Disease
NCT074703201 location
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
NCT067851161 location
Treatment With Aspirin After Preeclampsia: TAP Trial
NCT062816651 location
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
NCT064081811 location